The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain
ESPriT1
1 other identifier
interventional
7
1 country
1
Brief Summary
Endometriosis is a chronic, incurable condition that affects about 10% of women of reproductive age. It is defined as a growth of cells similar to the womb lining outside of the womb in the pelvis, and is associated with chronic pelvic pain, excessive period pain, pain with sexual intercourse and difficulties in getting pregnant. If the disease is found only on the lining of the pelvis it is known as "superficial peritoneal" and is usually treated during a laparoscopic surgery by cutting out (excision) or burning off (ablation). However, many women do not find improvement in their symptoms after the surgery and can have complications from the procedure. The aim of this study is to determine if removal of the superficial peritoneal endometriosis improves pain symptoms and quality of life, which method of removal (excision or ablation) is more effective or if surgical removal is of no benefit to the patients and can potentially cause harm. The investigators plan to recruit up to 90 women from four NHS hospitals in Scotland over a period of 12 months. Women who are attending gynaecology departments with pelvic pain who have not previously had a diagnosis of endometriosis via laparoscopy will be approached. Patients will be asked to read an information sheet about the trial. Women who consent to the trial will be randomised during the surgery, if superficial endometriosis is found, to either having the endometriosis removed or not. For this pilot, follow up will be at 3 and 6 months (and obtain permission to continue to follow them up at 12 and 24 months should time and finding permit). Patients who do not consent to take part in the trial will be asked if the investigators can collect data on their demographics and reasons on why they did not wish to take part.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 15, 2019
CompletedFirst Posted
Study publicly available on registry
September 9, 2019
CompletedStudy Start
First participant enrolled
September 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2021
CompletedJune 13, 2024
June 1, 2024
1.5 years
August 15, 2019
June 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of women with suspected SPE undergoing diagnostic laparoscopy that were approached for the study an agreed to randomisation
The proportion of screened women who are eligible for the trial determined from the screening logs
Screening
Secondary Outcomes (19)
Baseline characteristics of eligible women that agree to be randomised and those that decline participation
Screening
Proportion of women having laparoscopy for investigation of chronic pelvic pain that are eligible (i.e. have only SPE) for the trial
visit 2 (day of surgery)
Effects of treatment and variability in treatment outcomes
visit 2 (day of surgery), 30 days post surgery
Improvement in quality of life
30 days post surgery, follow up at 3 and 6 months
Improvement in quality of life
day of surgery, follow up at 3 and 6 months
- +14 more secondary outcomes
Study Arms (2)
Surgical treatment
ACTIVE COMPARATORNo surgical treatment
NO INTERVENTIONInterventions
In the active comparator group patients will have endometriosis lesions removed by ablation or excision. Patients randomised to no surgical treatment arm will not have lesions removed and will only be given diagnosis on whether endometriosis was found or not.
Eligibility Criteria
You may qualify if:
- Undergoing laparoscopy for the investigation of chronic pelvic pain
- In order to be randomised, isolated superficial peritoneal endometriosis (SPE) must be identified at laparoscopy (macroscopically)
- Able to give informed consent
You may not qualify if:
- Previous surgical diagnosis of endometriosis
- Pregnant or are actively trying for pregnancy within the next six months
- Deep endometriosis or ovarian endometrioma on imaging or at laparoscopy
- Peritoneal 'pockets' only noted at laparoscopy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Edinburghlead
- NHS Grampiancollaborator
- University of Nottinghamcollaborator
Study Sites (1)
Royal Infirmary of Edinburgh
Edinburgh, United Kingdom
Related Publications (1)
Whitaker LHR, Doust A, Stephen J, Norrie J, Cooper K, Daniels J, Hummelshoj L, Cox E, Beatty L, Chien P, Madhra M, Vincent K, Horne AW. Laparoscopic treatment of isolated superficial peritoneal endometriosis for managing chronic pelvic pain in women: study protocol for a randomised controlled feasibility trial (ESPriT1). Pilot Feasibility Stud. 2021 Jan 7;7(1):19. doi: 10.1186/s40814-020-00740-9.
PMID: 33413677DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Andrew W Horne, Prof
University of Edinburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- General Practitioner
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 15, 2019
First Posted
September 9, 2019
Study Start
September 30, 2019
Primary Completion
April 1, 2021
Study Completion
April 1, 2021
Last Updated
June 13, 2024
Record last verified: 2024-06